SpacDeskBetter Therapeutics, Inc.
Completed deSPAC · 1 SPAC · 1 closed · 0 announced
Mountain Crest Acquisition Corp. II, listed on Nasdaq under the ticker MCAD and sponsored by Mountain Crest Capital LLC, was a blank-check company formed to target opportunities in the healthcare and medtech sector. The SPAC completed its IPO in 2020 and announced a definitive business combination with Better Therapeutics, Inc. in April 2021. Better Therapeutics is a San Francisco-based company developing prescription digital therapeutics designed to treat cardiometabolic diseases. The transaction has since closed, bringing Better Therapeutics to the public markets. For comprehensive deal timelines, filing history, and SPAC analytics on this and thousands of other transactions, sign up for full data access at SpacDesk.
SPAC Counterparty (1)
| Symbol | Issuer | Status | Announced | Close | IPO Size | PIPE | Sponsor |
|---|---|---|---|---|---|---|---|
| MCAD | Mountain Crest Acquisition Corp. II | Closed | 2021-04-07 | 2021-10-28 | $50.0M | $50.0M | Mountain Crest Capital LLC |